Resultados de la búsqueda 121-130 of 3009 for ������������KA���:ZA31���24������ ���������������������������������

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  2. Prophylactic Table ID File.indd

    Page 1.

  3. Centro Pediátrico de Mayo Clinic - Noticias

    diciembre 2024. Pokémon party at Mayo Clinic Children's Center brings joy, lasting memories Dec. 24, 2024, 05:00 p.m. CDT. noviembre 2024. Grateful heart still ...

  4. Procedimiento de Whipple - Médicos y departamentos - Mayo Clinic

    Overview of surgery in the treatment of exocrine pancreatic cancer and prognosis. https://www.uptodate.com/contents/search. Accessed March 24, 2023. Bergquist ...

  5. Cancer Physician Update e-Edition, August 2015

    23-24, 2015, in Amelia Island, Fla. This multidisciplinary review of nonmelanoma skin cancer (NMSC) and malignant melanoma includes current standards of ...

  6. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

    Rochester, Minn. The purpose of this study is to evaluate the effectiveness, safety, tolerability, and PK of INCB000928 over a 24-week treatment period followed ...

  7. Cirugía - Ensayos clínicos - Mayo Clinic

    ... 24; Month 6) Visit 9 (Week 52; Month 12). Visit 10 (Week 104, Month 24). Mayo Clinic Upper Digestive Disease Survey. Rochester, Minn. The Mayo Clinic Upper ...

  8. Cirugía - Ensayos clínicos - Mayo Clinic

    ... 24; Month 6) Visit 9 (Week 52; Month 12). Visit 10 (Week 104, Month 24). Mayo Clinic Upper Digestive Disease Survey. Rochester, Minn. The Mayo Clinic Upper ...

  9. Cirugía - Ensayos clínicos - Mayo Clinic

    ... 24; Month 6) Visit 9 (Week 52; Month 12). Visit 10 (Week 104, Month 24). Mayo Clinic Upper Digestive Disease Survey. Rochester, Minn. The Mayo Clinic Upper ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine the response rate to PLX-038 in patients with metastatic ovarian, primary peritoneal, and fallopian tube cancers that ...